{"id":"W2107570706","doi":"10.1245/s10434-011-2190-5","title":"Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132","year":2011,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; GiST; Imatinib mesylate; Imatinib; Internal medicine; Oncology; Adjuvant therapy; Stromal tumor; Surgical oncology; Progression-free survival; Surgery; Chemotherapy; Stromal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001375535,0.0003213923,0.001758509,0.0002480558,0.00007453574,0.000004523599,0.0001735942,0.00007636781,0.0001119745],"category_scores_gemma":[0.0004259788,0.0002423311,0.0003715499,0.0001859975,0.0005049911,0.0001524217,0.0001103873,0.0002695214,0.000001540225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007417787,"about_ca_system_score_gemma":0.000569126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008706606,"about_ca_topic_score_gemma":0.00001744381,"domain_scores_codex":[0.9965685,0.0003765922,0.00153522,0.0004800036,0.000403049,0.0006366541],"domain_scores_gemma":[0.9965626,0.001111054,0.001009199,0.0003051501,0.0006066114,0.0004053781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5443311,0.018861,0.001026493,0.000290143,0.0002948997,0.0009278512,0.000381809,0.000002197974,0.0135739,0.0003154435,0.0002555533,0.4197396],"study_design_scores_gemma":[0.4245596,0.5282078,0.006913635,0.0005966289,0.0002389264,0.001588129,0.0001647942,0.0001680794,0.03503624,0.0003277042,0.001983717,0.0002146542],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993419,0.0009973458,0.0002188049,0.001082355,0.0001308202,0.002401654,0.000300515,0.00002100972,0.001428518],"genre_scores_gemma":[0.9822912,0.002269918,0.01462844,0.00005365399,0.00008445687,0.0002012058,0.0003528814,0.00002948098,0.00008874347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5093468,"threshold_uncertainty_score":0.9881976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1420351879950131,"score_gpt":0.4189234226879242,"score_spread":0.276888234692911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}